272 related articles for article (PubMed ID: 36322628)
1. Hormonal therapies up-regulate MANF and overcome female susceptibility to immune checkpoint inhibitor myocarditis.
Zhang Y; Sun C; Li Y; Qin J; Amancherla K; Jing Y; Hu Q; Liang K; Zhang Z; Ye Y; Huang LA; Nguyen TK; Egranov SD; Zhao Z; Wu A; Xi Y; Yao J; Hung MC; Calin GA; Cheng J; Lim B; Lehmann LH; Salem JE; Johnson DB; Curran MA; Yu D; Han L; Darabi R; Yang L; Moslehi JJ; Lin C
Sci Transl Med; 2022 Nov; 14(669):eabo1981. PubMed ID: 36322628
[TBL] [Abstract][Full Text] [Related]
2. Expansion of Pathogenic Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis.
Ma P; Liu J; Qin J; Lai L; Heo GS; Luehmann H; Sultan D; Bredemeyer A; Bajapa G; Feng G; Jimenez J; He R; Parks A; Amrute J; Villanueva A; Liu Y; Lin CY; Mack M; Amancherla K; Moslehi J; Lavine KJ
Circulation; 2024 Jan; 149(1):48-66. PubMed ID: 37746718
[TBL] [Abstract][Full Text] [Related]
3. Heart-Specific Immune Responses in an Animal Model of Autoimmune-Related Myocarditis Mitigated by an Immunoproteasome Inhibitor and Genetic Ablation.
Bockstahler M; Fischer A; Goetzke CC; Neumaier HL; Sauter M; Kespohl M; Müller AM; Meckes C; Salbach C; Schenk M; Heuser A; Landmesser U; Weiner J; Meder B; Lehmann L; Kratzer A; Klingel K; Katus HA; Kaya Z; Beling A
Circulation; 2020 Jun; 141(23):1885-1902. PubMed ID: 32160764
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of low-intensity pulsed ultrasound on immune checkpoint inhibitor-related myocarditis via fine-tuning CD4
Fu S; Guo Z; Xu X; Li Y; Choi S; Zhao P; Shen W; Gao F; Wang C; Chen S; Li Y; Tian J; Sun P
Cancer Immunol Immunother; 2024 Jan; 73(1):15. PubMed ID: 38236243
[TBL] [Abstract][Full Text] [Related]
5. Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Zhu H; Galdos FX; Lee D; Waliany S; Huang YV; Ryan J; Dang K; Neal JW; Wakelee HA; Reddy SA; Srinivas S; Lin LL; Witteles RM; Maecker HT; Davis MM; Nguyen PK; Wu SM
Circulation; 2022 Jul; 146(4):316-335. PubMed ID: 35762356
[TBL] [Abstract][Full Text] [Related]
6. Mesencephalic astrocyte-derived neurotrophic factor protects the heart from ischemic damage and is selectively secreted upon sarco/endoplasmic reticulum calcium depletion.
Glembotski CC; Thuerauf DJ; Huang C; Vekich JA; Gottlieb RA; Doroudgar S
J Biol Chem; 2012 Jul; 287(31):25893-904. PubMed ID: 22637475
[TBL] [Abstract][Full Text] [Related]
7.
Boughdad S; Latifyan S; Fenwick C; Bouchaab H; Suffiotti M; Moslehi JJ; Salem JE; Schaefer N; Nicod-Lalonde M; Costes J; Perreau M; Michielin O; Peters S; Prior JO; Obeid M
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34686542
[TBL] [Abstract][Full Text] [Related]
8. Cardiac myosin-specific autoimmune T cells contribute to immune-checkpoint-inhibitor-associated myocarditis.
Won T; Kalinoski HM; Wood MK; Hughes DM; Jaime CM; Delgado P; Talor MV; Lasrado N; Reddy J; Čiháková D
Cell Rep; 2022 Nov; 41(6):111611. PubMed ID: 36351411
[TBL] [Abstract][Full Text] [Related]
9. Mono-macrophage-Derived MANF Alleviates Bacterial Myocarditis by Inhibiting NF-kappaB Activation and Myocardial Inflammation.
Wang C; Bao Q; Hou C; Sun M; Song X; Cao S; Wang X; Shen Q; Zhao Y; Wang D
Inflammation; 2021 Oct; 44(5):1916-1926. PubMed ID: 33939070
[TBL] [Abstract][Full Text] [Related]
10. Treatment strategy for myocarditis in patients using immune checkpoint inhibitors or combined anti-vascular endothelial growth factor therapy by clinical severity.
Liu Q; Yu Y; Lin J; Wang Y; Ai L; Li Q; Wu W; Jin H; Li S; Liu M; Yu S; Liu T
Eur J Cancer; 2021 Nov; 157():10-20. PubMed ID: 34464781
[TBL] [Abstract][Full Text] [Related]
11. Previous cardiovascular injury is a prerequisite for immune checkpoint inhibitor-associated lethal myocarditis in mice.
Rubio-Infante N; Castillo EC; Alves-Figueiredo H; Ramos-González M; Salazar-Ramírez F; Salas-Treviño D; Soto-Domínguez A; Lozano O; García-Rivas G; Torre-Amione G
ESC Heart Fail; 2024 Apr; 11(2):1249-1257. PubMed ID: 38049390
[TBL] [Abstract][Full Text] [Related]
12. Re-introducing immunotherapy in patients surviving immune checkpoint inhibitors-mediated myocarditis.
Peleg Hasson S; Salwen B; Sivan A; Shamai S; Geva R; Merimsky O; Raphael A; Shmilovich H; Moshkovits Y; Kapusta L; Rozenbaum Z; Wolf I; Laufer-Perl M
Clin Res Cardiol; 2021 Jan; 110(1):50-60. PubMed ID: 32296970
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Glucocorticoid Effect Observation in a Ureteral Urothelial Cancer Patient With ICI-Associated Myocarditis and Multiple Organ Injuries.
Hu X; Wei Y; Shuai X
Front Immunol; 2021; 12():799077. PubMed ID: 34975911
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features of immune checkpoint inhibitor-related myositis in patients with urological cancer].
Ying YC; Tang Q; Yang KW; Mi Y; Fan Y; Yu W; Song Y; He ZS; Zhou LQ; Li XS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):644-651. PubMed ID: 35950386
[TBL] [Abstract][Full Text] [Related]
15. Myocarditis in Patients Treated With Immune Checkpoint Inhibitors.
Mahmood SS; Fradley MG; Cohen JV; Nohria A; Reynolds KL; Heinzerling LM; Sullivan RJ; Damrongwatanasuk R; Chen CL; Gupta D; Kirchberger MC; Awadalla M; Hassan MZO; Moslehi JJ; Shah SP; Ganatra S; Thavendiranathan P; Lawrence DP; Groarke JD; Neilan TG
J Am Coll Cardiol; 2018 Apr; 71(16):1755-1764. PubMed ID: 29567210
[TBL] [Abstract][Full Text] [Related]
16. Clinical Strategy for the Diagnosis and Treatment of Immune Checkpoint Inhibitor-Associated Myocarditis: A Narrative Review.
Lehmann LH; Cautela J; Palaskas N; Baik AH; Meijers WC; Allenbach Y; Alexandre J; Rassaf T; Müller OJ; Aras M; Asnani AH; Deswal A; Laufer-Perl M; Thuny F; Kerneis M; Hayek SS; Ederhy S; Salem JE; Moslehi JJ
JAMA Cardiol; 2021 Nov; 6(11):1329-1337. PubMed ID: 34232253
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular adverse events are associated with usage of immune checkpoint inhibitors in real-world clinical data across the United States.
Jain P; Gutierrez Bugarin J; Guha A; Jain C; Patil N; Shen T; Stanevich I; Nikore V; Margolin K; Ernstoff M; Velcheti V; Barnholtz-Sloan J; Dowlati A
ESMO Open; 2021 Oct; 6(5):100252. PubMed ID: 34461483
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory treatment of immune checkpoint inhibitor-induced myocarditis: Pathway toward precision-based therapy.
Balanescu DV; Donisan T; Palaskas N; Lopez-Mattei J; Kim PY; Buja LM; McNamara DM; Kobashigawa JA; Durand JB; Iliescu CA
Cardiovasc Pathol; 2020; 47():107211. PubMed ID: 32268262
[TBL] [Abstract][Full Text] [Related]
19. Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis.
Awadalla M; Mahmood SS; Groarke JD; Hassan MZO; Nohria A; Rokicki A; Murphy SP; Mercaldo ND; Zhang L; Zlotoff DA; Reynolds KL; Alvi RM; Banerji D; Liu S; Heinzerling LM; Jones-O'Connor M; Bakar RB; Cohen JV; Kirchberger MC; Sullivan RJ; Gupta D; Mulligan CP; Shah SP; Ganatra S; Rizvi MA; Sahni G; Tocchetti CG; Lawrence DP; Mahmoudi M; Devereux RB; Forrestal BJ; Mandawat A; Lyon AR; Chen CL; Barac A; Hung J; Thavendiranathan P; Picard MH; Thuny F; Ederhy S; Fradley MG; Neilan TG
J Am Coll Cardiol; 2020 Feb; 75(5):467-478. PubMed ID: 32029128
[TBL] [Abstract][Full Text] [Related]
20. Cardiac MRI Depicts Immune Checkpoint Inhibitor-induced Myocarditis: A Prospective Study.
Faron A; Isaak A; Mesropyan N; Reinert M; Schwab K; Sirokay J; Sprinkart AM; Bauernfeind FG; Dabir D; Pieper CC; Heine A; Kuetting D; Attenberger U; Landsberg J; Luetkens JA
Radiology; 2021 Dec; 301(3):602-609. PubMed ID: 34581628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
